Fidelity Advisor® Biotechnology Fund

Scorecard
4 / 5 Stars
Lipper
5 4 4 2 4
Zacks Investment Research
3 (Hold)
Standard & Poor's
5 / 5 Stars
TheStreet.com
A (Buy)

Fund Holdings

Asset Allocation

% Long % Net
Cash 4.09 4.09
Stocks 93.71 93.71
Bonds 0.0 0.0
Other 0.0 0.0
Foreign Bonds 0.0 0.0
Foreign Stocks 1.99 1.99
Convertible 0.0 0.0
Preferred 0.2 0.2

Updated 12.31.2013

Top 10 Holdings

Performance as of 02.28.2014

Portfolio as of 12.31.2013

Ticker YTD Return % % Net Assets
Gilead Sciences Inc GILD 8.46 15.63
Amgen Inc AMGN 8.96 10.28
Biogen Idec Inc BIIB 21.04 7.93
Celgene Corporation CELG -5.14 7.6
Alexion Pharmaceuticals, Inc. ALXN 29.76 4.41
Regeneron Pharmaceuticals, Inc. REGN 23.35 3.48
Vertex Pharmaceuticals VRTX 9.77 2.89
Aegerion Pharmaceuticals, Inc. AEGR -23.55 1.71
Biomarin Pharmaceutical, Inc. BMRN 13.32 1.63
United Therapeutics Corporation UTHR -11.24 1.58